Skip to main content
Original Research
A Retrospective Chart Review on the Toxicity of Pegylated Asparaginase in Adult Patients with Acute Lymphoblastic Leukemia
Cindy Ippoliti, PharmD, Monank Patel, PharmD
Read More
FDA Updates
Concise Review of Obinutuzumab in the Treatment of Patients with Chronic Lymphocytic Leukemia
Peter Tang, PharmD Candidate, Tristan Lindfelt, PharmD, BCPS, BCACP, BCOP, Robert J. Ignoffo, PharmD, FASHP, FCSHP, FHOPA
Read More
FDA Updates
Recent Cancer Drugs Approved by the FDA
Read More
From the Literature
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy
Read More
Original Research
Evaluation of G-CSF Use in a Single Institution and Development of Pocket Reference for Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia
Taylor W. Butler, PharmD, J. Aubrey Waddell, PharmD, Brad J. Crane, PharmD
Read More
FDA Updates
Recent Cancer Drugs Approved by the FDA
Read More
Original Research
Successful Panitumumab Administration after Cetuximab-Induced Aseptic Meningitis: A Case Report and Review
Jane E. Rogers, PharmD, BCOP, Lindsey Law, MPAS, PA-C, Rachna Shroff, MD, MS
Read More
Concise Reviews of Studies Relevant to Hematology Oncology Pharmacy
Read More
IMBRUVICA™ Approved For Previously Treated Chronic Lymphocytic Leukemia; Immediately Available Through Onco360®
Read More
Mekinist™ (trametinib) & Tafinlar® (dabrafenib) Approved In Combination; Both Limited Distribution Products Immediately Available Via Onco360®
Read More
Page 186 of 200
Results 1851 - 1860 of 1993